Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02003)

• Formulation Name: Atorvastatin 20 mg tablet
• Company: Aphena Pharma Solutions-Tennessee; Apotex; AvPAK; Cambridge Therapeutics Technologies; Cardinal Health; Carilion Materials Management; Clinical Solutions Wholesale; Golden State Medical Supply; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Legacy Pharmaceutical; Major Pharmaceuticals; MedVantx; NCS HealthCare of KY, Inc dba Vangard Labs; PD-Rx Pharmaceuticals; Proficient Rx; RemedyRepack; Unit Dose Services

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Atorvastatin	(DMF28YC)	Acute coronary syndrome	BA41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium acetate	(E00098)	6116	Antimicrobial preservative; Complexing agent
Carbonic acid disodium salt	(E00199)	10340	Alkalizing agent; Buffering agent; Diluent; Dispersing agent
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent